Nomura Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.7M | Buy |
|
|||||
|
2025
Q1 | $74.3M | Buy |
|
|||||
|
2024
Q4 | $60.3M | Sell |
|
|||||
|
2024
Q3 | $72M | Buy |
|
|||||
|
2024
Q2 | $69.4M | Buy |
|
|||||
|
2024
Q1 | $54.9M | Sell |
|
|||||
|
2023
Q4 | $61.3M | Sell |
|
|||||
|
2023
Q3 | $59M | Buy |
|
|||||
|
2023
Q2 | $58.3M | Sell |
|
|||||
|
2023
Q1 | $58.2M | Sell |
|
|||||
|
2022
Q4 | $85.6M | Sell |
|
|||||
|
2022
Q3 | $92.4M | Buy |
|
|||||
|
2022
Q2 | $88.2M | Sell |
|
|||||
|
2022
Q1 | $82.2M | Buy |
|
|||||
|
2021
Q4 | $65.2M | Buy |
|
|||||
|
2021
Q3 | $43.7M | Buy |
|
|||||
|
2021
Q2 | $46M | Sell |
|
|||||
|
2021
Q1 | $51.4M | Sell |
|
|||||
|
2020
Q4 | $59.3M | Buy |
|
|||||
|
2020
Q3 | $65.3M | Buy |
|
|||||
|
2020
Q2 | $53.1M | Buy |
|
|||||
|
2020
Q1 | $40.7M | Buy |
|
|||||
|
2019
Q4 | $12.7M | Sell |
|
|||||
|
2019
Q3 | $10.4M | Buy |
|
|||||
|
2019
Q2 | $10.6M | Sell |
|
|||||
|
2019
Q1 | $10.7M | Sell |
|
|||||
|
2018
Q4 | $9.88M | Buy |
|
|||||
|
2018
Q3 | $10.8M | Buy |
|
|||||
|
2018
Q2 | $9.41M | Sell |
|
|||||
|
2018
Q1 | $9.26M | Buy |
|
|||||
|
2017
Q4 | $8.34M | Buy |
|
|||||
|
2017
Q3 | $4.83M | Sell |
|
|||||
|
2017
Q2 | $6.86M | Buy |
|
|||||
|
2017
Q1 | $5.66M | Buy |
|
|||||
|
2016
Q4 | $2.73M | Sell |
|
|||||
|
2016
Q3 | $4.59M | Buy |
|
|||||
|
2016
Q2 | $4.45M | Buy |
|
|||||
|
2016
Q1 | $2.9M | Buy |
|
|||||
|
2015
Q4 | $3.61M | Sell |
|
|||||
|
2015
Q3 | $3.62M | Buy |
|
|||||
|
2015
Q2 | $4.12M | Sell |
|
|||||
|
2015
Q1 | $4.39M | Buy |
|
|||||
|
2014
Q4 | $4.03M | Buy |
|
|||||
|
2014
Q3 | $3.02M | Buy |
|
|||||
|
2014
Q2 | $2.38M | Buy |
|
|||||
|
2014
Q1 | $1.77M | Sell |
|
|||||
|
2013
Q4 | $2.54M | Buy |
|
|||||
|
2013
Q3 | $1.95M | Sell |
|
|||||
|
2013
Q2 | $2.65M | Buy |
|